Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Graphite Bio, Inc. Common Stock (GRPH)

Biological Products, (no Disgnostic Substances)

https://www.graphitebio.com

Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire disease-causing genes with normal genes, or insert new genes into predetermined, safe locations. Its product candidate GPH101 is a differentiated approach with the potential to directly correct the mutation that causes sickle cell disease (SCD) and restore normal adult hemoglobin (HgbA) expression. All of the company's long-lived assets are based in the United States.

611 GATEWAY BLVD, SUITE 120
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/25/2021

Market Cap

185,193,342

Shares Outstanding

58,000,000

Weighted SO

58,221,760

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.1960

Last Div

2.0600

Range

3.05-29.82

Chg

-0.0900

Avg Vol

40955

Mkt Cap

185193342

Exch

NASDAQ

Country

US

Phone

650 484 0886

DCF Diff

-0.0735

DCF

3.2535

Div Yield

0.3239

P/S

18.0924

EV Multiple

0.3899

P/FV

0.0757

Div Yield %

32.3899

P/E

-0.1278

PEG

0.0052

Payout

0.0000

Current Ratio

11.4715

Quick Ratio

11.2918

Cash Ratio

10.6076

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

856.1891

CCC

-856.1891

Gross Margin

0.7030

Op Margin

-11.1250

Pretax Margin

-11.4659

Net Margin

-11.4659

Eff Tax Rate

-0.0214

ROA

-0.5401

ROE

-0.5796

ROCE

-0.5739

NI/EBT

1.0000

EBT/EBIT

1.0306

EBIT/Rev

-11.1250

Debt Ratio

0.0007

D/E

0.0008

LT Debt/Cap

0.0008

Total Debt/Cap

0.0008

Int Coverage

21.7445

CF/Debt

-595.3205

Equity Multi

1.0967

Rec Turnover

0.0000

Pay Turnover

0.4263

Inv Turnover

0.0000

FA Turnover

16.3254

Asset Turnover

0.0471

OCF/Share

-19.6858

FCF/Share

-21.9058

Cash/Share

45.2091

OCF/Sales

-9.0729

FCF/OCF

1.1128

CF Coverage

-595.3205

ST Coverage

0.0000

CapEx Coverage

-8.8676

Div&CapEx Cov

-8.8676

P/BV

0.0757

P/B

0.0757

P/S

18.0924

P/E

-0.1278

P/FCF

-1.7920

P/OCF

-0.1615

P/CF

-0.1615

PEG

0.0052

P/S

18.0924

EV Multiple

0.3899

P/FV

0.0757

DPS

1.0300

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.15 03/22/2024 11/30/-0001 11/30/-0001 11/30/-0001